Copernicus Receives Milestone Payment From CFFT To Further Development Of Its Non-Viral Gene Therapy For Cystic Fibrosis
Dec 15th 2007Drug InformationCystic Fibrosis
Copernicus Therapeutics, Inc. announced that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit affiliate of the Cystic Fibrosis Foundation. This milestone payment is part of a research, development, and commercialization agreement between CFFT and Copernicus to develop gene therapy to treat cystic fibrosis. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
